Document is current

Article History

Accepted: 23 January 2021

First Online: 23 February 2021

Declarations

:

: Open Access funding provided by Universität Zürich. No sources of funding were used to conduct this study or prepare this manuscript.

: Dr. Galovic has received fees and honoraria from Nestlé Health Science and Scope International. Dr. Zelano has been an investigator in clinical trials sponsored by Bial, SK Life science, UCB, and GW Pharma as an employee of Sahlgrenska University hospital (without personal compensation) and has received speaker honoraria at educational meetings organized by UCB and Eisai. Dr. Koepp has been an investigator in clinical trials sponsored by Bial, Novartis, Desitin, and UCB and has received honoraria from UCB, GSK, Novartis, Bial, Eisai, Desitin, and GE-Healthcare. Carolina Ferreira-Atuesta, Laura Abraira, Nico Döhler, Lucia Sinka, Francesco Brigo, Carla Bentes, and Johan Zelano have no conflicts of interest that are directly relevant to the content of this article.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: All authors contributed sections to the first draft of the manuscript. MG combined the sections to a first draft. All authors revised the manuscript draft for intellectual content and read and approved the final version.